Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel and aspirin versus aspirin alone in symptomatic polyvascular disease
2008-004626-17Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clopidogrel and aspirin in panvascular disease, cardiac morbidity, peripheral artery occlusion (PAD) and 1 more (3 arms), sponsored by Policlinico Gemelli. Started Sep 2008; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
panvascular diseasecardiac morbidityperipheral artery occlusion (PAD)coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-004626-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004626-17.